formats

Reflections on the Withdrawal of Vioxx from the Market

Three years ago, at a journal club presentation at our hospital and on the hospital web site, I expressed my opinion that the data then available suggesting an excess cardiovascular risk from use of Vioxx (rofecoxib) were inconclusive. I based this opinion on the following. The data compared a large dose of Vioxx (50 mg

Read More…

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Reflections on the Withdrawal of Vioxx from the Market  comments